chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient experienced tingling tongue, dizziness, high blood pressure, and swelling of the eyes within 15 minutes post vaccination in the left deltoid. The patient was treated with oral Benadryl 25 mg and Pepcid 20 mg by mouth at 0820. Another dose of Benadryl 25 mg and Pepcid 20 mg was given to the patient at 09:00. She was then transported to the ED and her blood pressure at 09:31 was 193/122 and her respiratory rate was 21 on room air.  She was then given IV Benadryl 25 mg at 09:44, IV Pepcid 20 mg at 09:44, and methylprednisolone 125 mg. Normal saline 1000 mL drip was started at 09:45. Valsartan 40 mg was administered at 09:59.
Narrative:  79yo male pt died while inpatient at hospital hospice unit - Death was caused by: Acute hypoxic respiratory failure secondary to S maltophilia pneumonia. Pt had received covid vaccines on 2/14/21, 3/13/21, & 11/3/21. This death is not related to covid vaccines.
Pt to ED 11/17 for high blood sugar, n/v/d x 2 days. Pt COVID+ 11/17. 11/19 pt had flank pain this morning, having complaints of nausea. 11/21 reports minimal nausea no vomiting Reports left lower quadrant abdominal discomfort, denies right upper quadrant pain, no fevers no chills, finished 3-day course of remdesivir. 11/22 pt A/ox4, in room air, Denies pain, Ambulatory, Vtal signs stable. Pt discharged 11/22.
approx 2 1/2 hrs p/vax pt had high pitched screaming x 2 1/2 to 3 hrs cont; pt was pale w/episode; t103;
Indigestion, upset stomach  queasy weak dizzy fatigued elevated heart rate feeling wired but tired and could not sleep; insomnia red rosy cheeks fever muscle achiness and joint pain TMJ with intense stiffening of neck and jaw muscles swollen lymph under left arm  making lying on left side not possible for almost 3 days headache sensitivity to light  most symptoms lasted four full days and into the fifth.  I could not get out of bed  fatigue, weakness, disgestive upset and achy muschles/joints lasted several weeks  Today is 3/30 and I still do not feel as good and healthy and as well as I did in early september 2020 before I had the first dose of shingrix.
Client received single dose Cansino Covid vaccine with no reaction. Vaccine not approved by the World Health Organization. Janssen given as an alternative on 9.15.21.
Pt reported topical skin rash that appeared on chest approximately 2 days after vaccination. Rash subsequently spread to surface of entire trunk and down back of legs over the following 3-5 days. Pt also reported symptoms of sinus congestion, sore throat, and chest congestion (productive infrequent cough) that began approximately 3-4 days after vaccination. As of today - topical rash has mostly resolved; pt still reporting minor symptoms of sinus and chest congestion.
Child became limp and lost consciousness.  Child laid on table with feet elevated.  Did respond to name, but quickly lost consciousness again.  Child self-revived.  Blood Pressure was decreased but increased as he became more conscious.
Fever below 102F, runny nose and cough, red lacy rash over stomach, side and back.
After my first dose I had muscle twitching primarily in my left eyelid for about 2 weeks post the first dose. I also had random small twitches at random times throughout other muscles including my thigh, upper arms, and lower arms. After about two weeks it completely subsided. It is the morning after receiving my second dose and the eye twitching is back. It is not painful but is very annoying and inconvenient. Considering that it doesn't seem to be anything other then a nuisance I decided not to go seek medical treatment at an emergency facility. Unfortunately I cannot seem to get in touch with any family medicine clinics in my area because I just moved and they are all booked out for a month or two. I would like to know why this is happening though.
Extreme vertigo, dizziness all of 4/14 and slowly got manageable a day later.   At the time, symptoms of nausea along with the disorientation.  Pain at base of neck.  6 days and some dizziness when changing direction (head) and easily thrown off balance.  Feels like I am floating and my head has pressure.
Patient fainted about 5 mins after he  received Moderna Vaccine. He looked pale and sweating . He  woke up and  we gave him water, and paramedic came in to Pharmacy waiting room in 15 mins and took him to ER.
Spiked a fever one hour after receiving the H1N1 nasal mist. Temp. reached 101.7. It was 98 degrees prior to getting the vaccine. Temp. today is 102.3 degrees.
mild to moderate headache nearly everyday   sometimes not lasting all day  kinda feels like a migraine  light and heat sensitive  back of head left side side of head above ear behind eye neck into shoulder
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's current conditions, medical history and concomitant medications were not reported. The patient was vaccinated with the GARDASIL injection (confirmed not GARDASIL 9) on 09-JUN-2014, 19-AUG-2014 and 22-DEC-2014 (inappropriate schedule of drug administration). No adverse symptoms were reported. No further information was provided. Product quality complaint (PQC) was not involved. Additional information has been requested.
Anaphylaxis (SOB, rash, diarrhea, nausea, myalgias) within 24 hrs of vaccine administration.
Administered expired vaccine to patient, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patient, after the manufacture date of expiration.) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patient, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patient, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses. The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received contain non significant information.
Patient tested positive for COVID 11/03/2021 Arrived to ER on 11/3/2021 with cough, hypoxia (low to the 80's on room air), increased lethargy, shortness of breath
Fever, pain in arm and shudder, red, hot rash down arm and and across chest, nausea, fatigue and muscle aces!
Narrative:  Fully vaccinated, admitted for confusion and hyperactivity, incidental COVID positive
3 days after receiving MMR, Varivax, Hep A and influenza vaccines, patient had a temp of 102 and a generalized tonic clonic seizure.  Per parents, had stopped breathing during this episode and was given chest compression.  EMS arrived and brought patient to Hospital.  There she was observed overnight.  She had no further episodes and was released the next day.  1/15/08 Reviewed hospital medical records which reveal patient experienced fever, irritability, involuntary jerking all extremities, eyes rolling back, loss of consciousness, hypotonia, ashen gray.  Family felt was in cardiac arrest & started cpr for short time before patient began to breath.  EMS foung patient groggy alternating w/irritability/crying.  O2 sat dropped to 94% & placed on blowby O2.  Admitted 12/10-12/11/2007.  Returned to baseline while in ER but admitted for observation.  No further fever or seizure activity while in hospital.  D/C to home & pcp f/u. FINAL DX: febrile seizure.
Redness in the area, about 6 cm diameter, around the injection site, appeared morning of April 17, 2018, next day after injection; skin rash appeared on April 18, 2018 (two days after injection) - "spottiness" on upper body below head and above mid-section, both arms; fatigue with sleepiness afternoon of Tuesday, April 17, 2018 (one day after injection). All side effects appear to be subsiding, early evening, April 20, 2018.
Infant had fever afternoon following vaccine administration. She had what is believed to be a seizure. Presented to ED and was admitted for observation overnight. Infectious workup was negative. EEG was negative. Did not undergo MRI. She was seen by neurology and diagnosed with an atypical febrile seizure felt to be secondary to fever following vaccination. She was observed in the hospital overnight without any further episodes.
Approximately two hours post vaccination, the patient experienced soreness in left arm. The swollen area which was covered with red and itchy hives, was about three inches below the injection site. It continued to grow until it almost reach the elbow.The patient applied ice packs to the area and went to her PCP. The patient was informed by her PCP that the area was the result of an allergic-type reaction. Treatment consisted of anti-histamine and cold packs.  Patient experienced a similar reaction to the flu shot last year. Her PCP instructed to discontinue getting the flu vaccination, but to still receive the pneumococcal vaccine
Pt stated this began as a knot to injection site (left deltoid) almost immediately/the following day the injection was given. Started bruising, swelling and was painful. The bruise started spreading to left bicep and to lower arm. Pt applied ice which decreased swelling. Pt seen 8/10/2020 and was told to ice area and take ibuprofen for pain. Will return to office if it does not improve
4-month-old was administered a dose of Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 14th March 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 14th March 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that a 4 month old was administered a dose of Kinrix, which led to inappropriate age at vaccine administration. The reporter consented to follow up
11/10/09 Dizzy immediately after, nausea x 1 wk. Seen in ER 11/18/09, IV fluids, ZOFRAN. Pt became more ill with vomiting and cough 5 days after vaccine, diarrhea, cold symptoms, cough, congestion.
I woke up in the middle of the night with extreme abdominal pain, cramping, cold sweats,  diarrhea. I thought it would pass but the next day things did not get any bettor so I went to the emergency room in the afternoon. Several hours and tests later I was sent home with colitis diagnosis a 10 day course of antibiotics. I still have the occasional discomfort but am feeling much better.
. Following Covid-19 vaccine, patient complained of rapid heart rate @ 16:15. Vital signs were taken at 16:16: o2 Sat: 99%, Pulse: 76, BP: 200/99. Patient stated that she did not drink enough because she had a long commute home, and did not want to use the bathroom. RN recommended the patient to drink water, and handed her a bottle of water, which she drank completely. Vital signs were retaken at 16:21: o2 Sat: 100%, HR: 70, BP: 192/91. Patient was advised that she will be taken to the ER for continuous monitoring, but the patient insisted to decline, and stated that she did not want to go to the ER.
18 X 18 cm area of swelling and erythema on posterior arm  Given Kenalog 0.1% topical and Ibuprofen 800mg Q8 hours prn w/ food for discomfort
Information has been received on 22-FEB-2019 regarding a case in litigation concerning an approximately 54 year old female patient. The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 30-MAR-2017, the patient was administered the ZOSTAVAX vaccine (lot# and route not specified) by a pharmacist. In May 2017, the patient was treated by a physician for shingles as a result of vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
black floating inside; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (Batch/Lot Number: EL9264; Expiration Date: 31May2021), via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, it was reported that, one vial was received with something black floating inside. It was requested, the reporter to hold onto the product as it will be requested for the investigation. The outcome for the event was unknown.
Changes to menstrual cycle. Prior to vaccination, menstrual cycles averaged 29 days. Since vaccination, menstrual cycles have averaged 25 days
UTI; This is a spontaneous report from a contactable consumer (patient herself) and via report from a Pfizer-sponsored program. A 78-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: Not probed, Expiry Date: Unknown), via an unspecified route of administration on 12Apr2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (BNT162B2). She stated that she has a UTI and was given an antibiotic, Macrobid, and wanted to make sure it was not going to interact with the vaccine before she took it. She is on antibiotics now for her urinary tract infection. Consumer states that she gets a UTI about every other month. She would like to know if she can take her antibiotics or any other medication after the Covid-19 vaccine. On an unspecified date, the patient experienced UTI. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
This spontaneous report was received from a medical assistant and refers to a 4 year old patient of unknown gender. No information about the patient pertinent medical history, concurrent medications and drug reactions or allergies was provided. On 22-MAY-2018, the patient was vaccinated with improperly stored dose of PROQUAD, lot# N035173, expiration date 09-JUN-2019 (strength, dose, frequency and route of administration were not provided) for prophylaxis. Concomitant therapies included sterile diluent. The vaccine underwent temperature excursion on a freezer. The dose of PROQUAD was exposed to a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit during a time frame of 15 minutes, which was detected by the data logger. There was a previous temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 30 minutes. No adverse effects were reported. This is one of a several reports received from the same reporter. Sender's Comments: US-009507513-1807USA001194: US-009507513-1807USA001196: US-009507513-1807USA001197: US-009507513-1807USA001198: US-009507513-1807USA001199: US-009507513-1807USA001200: US-009507513-1807USA001201: US-009507513-1805USA010447.
Itching all over my body; This is a spontaneous report received from a contactable consumer. This consumer (patient) reported that:  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRURITUS (non-serious), outcome "unknown", described as "Itching all over my body".  Additional information: Patient took the Pfizer shot on Friday and patient woke up this morning and had got a lot of itching all over my body.  Follow-up attempts completed. No further information is expected.  Follow-up (08Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Moderna COVID-19 Vaccine EUA Fatigue, muscle & joint pains, chills, and slight fever - lasting 1 day after vaccine.  Headache and nausea lasting 2 days after vaccine.  Pain/soreness at injection site - lasting 3 days after vaccine.
Pt recv vax & exp low grade fever,h/a,sore muscles & sore joints. Sx reoccurred every 6-8 wk lasting 2-3 day per occurrence. No further information.
Discoloration of skin on left hand (side where vaccine was administered); This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL8982), via an unspecified route of administration in left arm, on 13Jan2021 at 17:30, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient previously took amoxicillin and experienced allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 14Jan2021 at 06:00 AM, the patient experienced discoloration of skin on left hand (side where vaccine was administered). The patient has not been tested for COVID-19 post-vaccination. No treatment was administered for the event. The patient had not recovered from the event.
Warm, erythematous, 5-cm plaque surrounding the site of injection. Diagnosed with cellulitis and prescribed antibiotics.
no adverse event; The patient  received two doses of the pneumonia vaccine within the last two months; This spontaneous case was received from a female consumer who at the time of the report was 70 years regarding on herself. The patient denied having concurrent conditions, historical conditions or allergies however, she reported to take levothyroxine sodium (SYNTHROID), unspecified blood pressure, and cholesterol medications as concomitant medications.   On an unspecified date in October 2019 (reported as at the end of October), the patient was vaccinated with the first dose of vaccine, polyvalent (23-valent)(PNEUMOVAX23) and on 26-NOV-2019 she received the second dose of vaccine, polyvalent (23-valent)(PNEUMOVAX23) (inappropriate schedule of product administration) indication reported as "Doctor suggested it" and route administration reported as injection, (strength, lot number and expiration date were not reported). No additional symptoms were reported and no adverse events.  Furthermore, no laboratory diagnostics or studies were performed, and the patient did not sought for medical attention.
Patient had fall x 2 with or without sycnope (conflicting documentation) with humeral fracture after recieving the vaccine. Workup demonstrated PE and DVT (appears PE was not submassive/massive, unlikely it directly precipitated fall/ syncope)
Itchy rash underneath his right nipple and pectoral muscle; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash underneath his right nipple and pectoral muscle) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Itchy rash underneath his right nipple and pectoral muscle). At the time of the report, RASH PRURITIC (Itchy rash underneath his right nipple and pectoral muscle) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient had been applying some antibiotic to the rash which seems to be helping with the itchiness.
Began 2/28/19-Redness approx. size of quarter. Not hot, some swelling, no fever. Parameters marked. Tender to touch, ice helps. Called urgent care 3/1/19. Recommended ER but ER said to watch not come. Gave BENADRYL, Tyl/Ibu. Came to head and patient scratched off - bled, drainage. Poss. insect bite. No increase swelling, redness.
Low grade fever; Aches; Fatigue; Chills; Nose bleed; This is a spontaneous report from a contactable consumer (patient). A 61-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number and Expiration date was unknown), via an unspecified route of administration, administered in left arm on 19Mar2021 at 11:45 hours as dose 2, single (at the age of 61-years-old) for COVID-19 immunisation. Medical history included papillary thyroid cancer from an unknown date and unknown if ongoing. Patient was not allergic to medications, food and other products. Historical vaccine included patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number and Expiration date was unknown), via an unspecified route of administration, administered in left arm on 26Feb2021 at 12:00 hours as dose 1, single (at the age of 61-years-old) for COVID-19 immunisation. Concomitant medication(s) included levothyroxine sodium (Synthroid) taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks, prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, at 06:00 hours, patient experienced low-grade fever, aches, chills, fatigue and nosebleed. The adverse event did not result in doctor or other healthcare professional office or clinic or emergency room visit. Therapeutic measures taken for all the events and treatment included Advil and Tylenol. The outcome of all the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient received 15-month vaccines a week ago.  That night she developed vomiting and diarrhea, thought most likely due to viral gastroenteritis.  She does attend daycare and there is viral gastroenteritis (suspected adenovirus) circulating in the local community.  2 days after vaccination, she had an episode of altered mental status/loss of consciousness for approximately 5 minutes and suspected seizure activity for 1 minute. EMS was called and she was admitted to Hospital. She was found to have borderline low blood glucose 61mg/dL, which was attributed to suspected viral gastroenteritis and thought to be the cause of her altered mental status/possible seizure.   Patient has a normal newborn screen x2.  She was born at a Hospital.  She has not had any previous hypoglycemic episodes or seizure-like activity.
Throat hurt 5/10, tearful, sniffling; Vital stable Resp rate 18-21 HR 70-82, PO2 100% Sitting  up, drank water, calmed down with mom Discharged: 16:02 - stable Home by car with mom. Walking normally unassisted. Pain reduced 3/10. Relaxed